2024-03-012025-02-282025-02-28false05366342Southern Implants U.K. Limited2025-11-1147749falseiso4217:GBPxbrli:pure053663422024-02-29053663422025-02-28053663422024-03-012025-02-28053663422023-02-28053663422024-02-29053663422023-03-012024-02-2905366342bus:SmallEntities2024-03-012025-02-2805366342bus:AuditExempt-NoAccountantsReport2024-03-012025-02-2805366342bus:FullAccounts2024-03-012025-02-2805366342bus:PrivateLimitedCompanyLtd2024-03-012025-02-2805366342core:WithinOneYear2025-02-2805366342core:AfterOneYear2025-02-2805366342core:WithinOneYear2024-02-2905366342core:AfterOneYear2024-02-2905366342core:ShareCapital2025-02-2805366342core:SharePremium2025-02-2805366342core:RevaluationReserve2025-02-2805366342core:OtherReservesSubtotal2025-02-2805366342core:RetainedEarningsAccumulatedLosses2025-02-2805366342core:ShareCapital2024-02-2905366342core:SharePremium2024-02-2905366342core:RevaluationReserve2024-02-2905366342core:OtherReservesSubtotal2024-02-2905366342core:RetainedEarningsAccumulatedLosses2024-02-2905366342core:LandBuildings2025-02-2805366342core:PlantMachinery2025-02-2805366342core:Vehicles2025-02-2805366342core:FurnitureFittings2025-02-2805366342core:OfficeEquipment2025-02-2805366342core:NetGoodwill2025-02-2805366342core:IntangibleAssetsOtherThanGoodwill2025-02-2805366342core:ListedExchangeTraded2025-02-2805366342core:UnlistedNon-exchangeTraded2025-02-2805366342core:LandBuildings2024-02-2905366342core:PlantMachinery2024-02-2905366342core:Vehicles2024-02-2905366342core:FurnitureFittings2024-02-2905366342core:OfficeEquipment2024-02-2905366342core:NetGoodwill2024-02-2905366342core:IntangibleAssetsOtherThanGoodwill2024-02-2905366342core:ListedExchangeTraded2024-02-2905366342core:UnlistedNon-exchangeTraded2024-02-2905366342core:LandBuildings2024-03-012025-02-2805366342core:PlantMachinery2024-03-012025-02-2805366342core:Vehicles2024-03-012025-02-2805366342core:FurnitureFittings2024-03-012025-02-2805366342core:OfficeEquipment2024-03-012025-02-2805366342core:NetGoodwill2024-03-012025-02-2805366342core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2805366342core:ListedExchangeTraded2024-03-012025-02-2805366342core:UnlistedNon-exchangeTraded2024-03-012025-02-2805366342core:MoreThanFiveYears2024-03-012025-02-2805366342core:Non-currentFinancialInstruments2025-02-2805366342core:Non-currentFinancialInstruments2024-02-2905366342dpl:CostSales2024-03-012025-02-2805366342dpl:DistributionCosts2024-03-012025-02-2805366342core:LandBuildings2024-03-012025-02-2805366342core:PlantMachinery2024-03-012025-02-2805366342core:Vehicles2024-03-012025-02-2805366342core:FurnitureFittings2024-03-012025-02-2805366342core:OfficeEquipment2024-03-012025-02-2805366342dpl:AdministrativeExpenses2024-03-012025-02-2805366342core:NetGoodwill2024-03-012025-02-2805366342core:IntangibleAssetsOtherThanGoodwill2024-03-012025-02-2805366342dpl:GroupUndertakings2024-03-012025-02-2805366342dpl:ParticipatingInterests2024-03-012025-02-2805366342dpl:GroupUndertakingscore:ListedExchangeTraded2024-03-012025-02-2805366342core:ListedExchangeTraded2024-03-012025-02-2805366342dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-03-012025-02-2805366342core:UnlistedNon-exchangeTraded2024-03-012025-02-2805366342dpl:CostSales2023-03-012024-02-2905366342dpl:DistributionCosts2023-03-012024-02-2905366342core:LandBuildings2023-03-012024-02-2905366342core:PlantMachinery2023-03-012024-02-2905366342core:Vehicles2023-03-012024-02-2905366342core:FurnitureFittings2023-03-012024-02-2905366342core:OfficeEquipment2023-03-012024-02-2905366342dpl:AdministrativeExpenses2023-03-012024-02-2905366342core:NetGoodwill2023-03-012024-02-2905366342core:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2905366342dpl:GroupUndertakings2023-03-012024-02-2905366342dpl:ParticipatingInterests2023-03-012024-02-2905366342dpl:GroupUndertakingscore:ListedExchangeTraded2023-03-012024-02-2905366342core:ListedExchangeTraded2023-03-012024-02-2905366342dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-03-012024-02-2905366342core:UnlistedNon-exchangeTraded2023-03-012024-02-2905366342core:NetGoodwill2025-02-2805366342core:IntangibleAssetsOtherThanGoodwill2025-02-2805366342core:LandBuildings2025-02-2805366342core:PlantMachinery2025-02-2805366342core:Vehicles2025-02-2805366342core:FurnitureFittings2025-02-2805366342core:OfficeEquipment2025-02-2805366342core:AfterOneYear2025-02-2805366342core:WithinOneYear2025-02-2805366342core:ListedExchangeTraded2025-02-2805366342core:UnlistedNon-exchangeTraded2025-02-2805366342core:ShareCapital2025-02-2805366342core:SharePremium2025-02-2805366342core:RevaluationReserve2025-02-2805366342core:OtherReservesSubtotal2025-02-2805366342core:RetainedEarningsAccumulatedLosses2025-02-2805366342core:NetGoodwill2024-02-2905366342core:IntangibleAssetsOtherThanGoodwill2024-02-2905366342core:LandBuildings2024-02-2905366342core:PlantMachinery2024-02-2905366342core:Vehicles2024-02-2905366342core:FurnitureFittings2024-02-2905366342core:OfficeEquipment2024-02-2905366342core:AfterOneYear2024-02-2905366342core:WithinOneYear2024-02-2905366342core:ListedExchangeTraded2024-02-2905366342core:UnlistedNon-exchangeTraded2024-02-2905366342core:ShareCapital2024-02-2905366342core:SharePremium2024-02-2905366342core:RevaluationReserve2024-02-2905366342core:OtherReservesSubtotal2024-02-2905366342core:RetainedEarningsAccumulatedLosses2024-02-2905366342core:NetGoodwill2023-02-2805366342core:IntangibleAssetsOtherThanGoodwill2023-02-2805366342core:LandBuildings2023-02-2805366342core:PlantMachinery2023-02-2805366342core:Vehicles2023-02-2805366342core:FurnitureFittings2023-02-2805366342core:OfficeEquipment2023-02-2805366342core:AfterOneYear2023-02-2805366342core:WithinOneYear2023-02-2805366342core:ListedExchangeTraded2023-02-2805366342core:UnlistedNon-exchangeTraded2023-02-2805366342core:ShareCapital2023-02-2805366342core:SharePremium2023-02-2805366342core:RevaluationReserve2023-02-2805366342core:OtherReservesSubtotal2023-02-2805366342core:RetainedEarningsAccumulatedLosses2023-02-2805366342core:AfterOneYear2024-03-012025-02-2805366342core:WithinOneYear2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:CostValuation2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-012025-02-2805366342core:Non-currentFinancialInstrumentscore:CostValuation2025-02-2805366342core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-02-2805366342core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2905366342core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2905366342core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2905366342bus:Director12024-03-012025-02-2805366342bus:Director22024-03-012025-02-2805366342bus:Director32024-03-012025-02-2805366342bus:Director42024-03-012025-02-2805366342core:FurnitureFittingsToolsEquipment2024-02-2905366342core:FurnitureFittingsToolsEquipment2024-03-012025-02-2805366342core:FurnitureFittingsToolsEquipment2025-02-28

Southern Implants U.K. Limited

Registered Number
05366342
(England and Wales)

Unaudited Financial Statements for the Year ended
28 February 2025

Southern Implants U.K. Limited
Company Information
for the year from 1 March 2024 to 28 February 2025

Directors

BLACKBEARD, Graham Alan
LUIZ, David John
ODENDAAL, Susan Isabel
SNOOK, Stephen James

Company Secretary

MILTIADES, Niki

Registered Address

Unit 1, Ilex House
94 Holly Road
Twickenham
TW1 4HF

Registered Number

05366342 (England and Wales)
Southern Implants U.K. Limited
Balance Sheet as at
28 February 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,468,0752,159
Investment property4509,927-
1,978,0022,159
Current assets
Stocks5984,123877,218
Debtors61,443,0051,427,794
Current asset investments664,217618,498
Cash at bank and on hand2,733,5783,830,938
5,824,9236,754,448
Creditors amounts falling due within one year7(1,373,550)(1,203,707)
Net current assets (liabilities)4,451,3735,550,741
Total assets less current liabilities6,429,3755,552,900
Provisions for liabilities8(68,211)(540)
Net assets6,361,1645,552,360
Capital and reserves
Called up share capital1,2501,250
Share premium37,45837,458
Profit and loss account6,322,4565,513,652
Shareholders' funds6,361,1645,552,360
The financial statements were approved and authorised for issue by the Board of Directors on 11 November 2025, and are signed on its behalf by:
SNOOK, Stephen James
Director
Registered Company No. 05366342
Southern Implants U.K. Limited
Notes to the Financial Statements
for the year ended 28 February 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The annual stock write-off is estimated based on the judgement of the managing director, who as an experienced salesman in this field, has the necessary expertise to judge the level of stock that has become obsolete or is worth less than the original cost price.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Land and buildings50
Plant and machinery6
Fixtures and fittings5
Vehicles4
Office Equipment3
Investments
Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Investment property
The investment property is accounted for under FRS 102, Section 16 Investment Property. Investment property is remeasured to fair value at each balance sheet date with fair value gains and losses being reported in profit or loss. Investment properties are valued using RICS open market valuation on a freehold basis.
Stocks and work in progress
Stock is valued at the lower of cost and estimated selling price less costs to complete and sell. The cost methodology employed by the entity is the first-in first-out method. Estimated selling price less costs to complete and sell are derived from the selling price which the goods would fetch in an open market transaction with established customers less the costs expected to be incurred to enable the sale to complete. Provision is made for slow-moving and obsolete items of stock. Such provisions are recognised in profit or loss.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year2018
3.Tangible fixed assets

Land & buildings

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

££££££
Cost or valuation
At 01 March 24---43564,78465,219
Additions1,323,56670,99912,75068,0405,8981,481,253
At 28 February 251,323,56670,99912,75068,47570,6821,546,472
Depreciation and impairment
At 01 March 24---43562,62563,060
Charge for year8,7988873,0641,1391,44915,337
At 28 February 258,7988873,0641,57464,07478,397
Net book value
At 28 February 251,314,76870,1129,68666,9016,6081,468,075
At 29 February 24----2,1592,159
4.Investment property
The investment property was acquired in November 2024. Following a review at the reporting date, the directors have concluded that a revaluation is not necessary, as there is no indication of a material change in fair value since acquisition.

£
Additions509,927
At 28 February 25509,927
5.Stocks

2025

2024

££
Finished goods984,123877,218
Total984,123877,218
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables1,227,2341,355,924
Other debtors178,95333,044
Prepayments and accrued income36,81838,826
Total1,443,0051,427,794
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables865,843703,736
Taxation and social security385,230443,700
Other creditors8,663-
Accrued liabilities and deferred income113,81456,271
Total1,373,5501,203,707
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)68,211540
Total68,211540